Page last updated: 2024-11-05

ticlopidine and Abnormalities, Autosome

ticlopidine has been researched along with Abnormalities, Autosome in 1 studies

Ticlopidine: An effective inhibitor of platelet aggregation commonly used in the placement of STENTS in CORONARY ARTERIES.
ticlopidine : A thienopyridine that is 4,5,6,7-tetrahydrothieno[3,2-c]pyridine in which the hydrogen attached to the nitrogen is replaced by an o-chlorobenzyl group.

Research Excerpts

ExcerptRelevanceReference
"Severe aplastic anemia is a well-recognized complication of ticlopidine therapy that carries a high mortality."2.41Ticlopidine-induced aplastic anemia: development of chromosomal abnormalities and response to immunosuppressive therapy. ( Liebman, HA; Murata-Collins, JL; Pullarkat, VA; Rho, H, 2000)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Pullarkat, VA1
Rho, H1
Murata-Collins, JL1
Liebman, HA1

Reviews

1 review available for ticlopidine and Abnormalities, Autosome

ArticleYear
Ticlopidine-induced aplastic anemia: development of chromosomal abnormalities and response to immunosuppressive therapy.
    American journal of hematology, 2000, Volume: 63, Issue:3

    Topics: Aged; Aged, 80 and over; Anemia, Aplastic; Bone Marrow; Chromosome Aberrations; Chromosome Disorders

2000